Aclaris Therapeutics, Inc.ACRSNASDAQ
LOADING
|||
ROE: Returns Declining
Trending lower, strong compound growth.
Left:
||||
Return on equity
Latest
-84.90%
↓ 15% below average
Average (9y)
-74.02%
Historical baseline
Range
High:-22.23%
Low:-230.80%
CAGR
+16.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -84.90% | -50.8% |
| 2023 | -56.29% | -28.0% |
| 2022 | -43.98% | +4.5% |
| 2021 | -46.04% | +66.0% |
| 2020 | -135.50% | +41.3% |
| 2019 | -230.80% | -274.0% |
| 2018 | -61.70% | -102.8% |
| 2017 | -30.42% | -7.2% |
| 2016 | -28.37% | -27.6% |
| 2015 | -22.23% | - |